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The biosynthetic gene cluster for the anticancer drug bleomycin
from Streptomyces verticillus ATCC15003 as a model for hybrid
peptide–polyketide natural product biosynthesis
B. Shen, L. Du, C. Sanchez, D.J. Edwards, M. Chen, and J.M. Murrell
Department of Chemistry, University of California, Davis, One Shields Avenue, Davis, CA 95616, USA

Abstract: The hybrid peptide–polyketide backbone of bleomycin (BLM) is assembled by the BLM megasynthetase that consists of
both nonribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) modules. BlmIX/BlmVIII/BlmVII constitute a natural
hybrid NRPS/PKS/NRPS system, serving as a model for both hybrid NRPS/PKS and PKS/NRPS systems. Sequence analysis and
functional comparison of domains and modules of BlmIX/BlmVIII/BlmVII with those of nonhybrid NRPS and PKS systems suggest
that (1) the same catalytic sites appear to be conserved in both hybrid NRPS–PKS and nonhybrid NRPS or PKS systems, with
the exception of the KS domains in the hybrid NRPS/PKS systems that are unique; (2) specific interpolypeptide linkers may play a
critical role in intermodular communication to facilitate transfer of the growing intermediates between the interacting NRPS and/or
PKS modules; and (3) posttranslational modification of the BLM megasynthetase has been accomplished by a single PPTase with
a broad substrate specificity toward the apo forms of both acyl carrier proteins (ACPs) and peptidyl carrier proteins (PCPs).
Keywords: biosynthesis, bleomycin, hybrid peptide–polyketide, nonribosomal peptide synthetase, polyketide synthase, Streptomyces verticillus

Nonribosomal peptides and polyketides are two large families of natural products that include many clinically valuable
drugs, such as vancomycin and erythromycin (antibacterial),
cyclosporin and rapamycin (immunosuppressant), and bleomycin (BLM) and epothilone (antitumor). The biosynthesis of
nonribosomal peptides and polyketides are catalyzed by nonribosomal peptide synthetases (NRPSs) and polyketide synthases
(PKSs), respectively. NRPSs and PKSs apparently use a very
similar strategy for the assembly of these two distinct classes
of natural products by sequential condensation of amino acids
and short carboxylic acids, respectively. Both NRPSs and type
I PKSs are multifunctional proteins that are organized into
modules. The number and order of modules on each NRPS or
PKS protein determine the structural variations of the resulting peptide and polyketide products. Both systems use carrier
proteins, peptidyl carrier protein (PCP) for NRPS and acyl carrier protein (ACP) for PKS, that are posttranslationally modified with the same 4′-phosphopantetheine prosthetic group to
channel the growing peptide or polyketide intermediate during
the elongation processes [2–4,19,30]. The latter modification
is catalyzed by a family of 4′-phosphopantetheineyl transferases (PPTases) (Figure 1A) [20,31]. These striking structural
and catalytic similarities between NRPSs and PKSs support
the idea of combining individual NRPS and PKS modules into
hybrid NRPS– PKS systems, in which an NRPS-bound growing peptidyl intermediate could be directly elongated by a PKS
module (Figure 1B) or vice versa (Figure 1C) [3,4,8,10]. Since
the modular architecture of both NRPSs and PKSs has been
exploited successfully in the combinatorial biosyntheses of diverse “unnatural” natural products [2–4], it is imagined that hybrid NRPS–PKS systems, capable of incorporating both amino

acids and short carboxylic acids into the final products, could
lead to even greater chemical structural diversity.
We have been studying the biochemistry and genetics of
BLM biosynthesis in Streptomyces verticillus ATCC15003
as a model for the biosynthesis of hybrid peptide–polyketide
natural products [6–10,23,24]. Here we summarize our findings on (1) functional interactions between BLM NRPS and
PKS modules that represent a natural hybrid NRPS–PKS system and (2) posttranslational modification of the BLM megasynthetase by the Svp PPTase that exhibits a broad substrate
specificity toward both ACPs and PCPs. These results shed
light on the molecular basis for a functional hybrid NRPS–
PKS system.
BLM as an example of natural hybrid peptide–
polyketide metabolites
The BLMs, a family of anticancer antibiotics produced by
S. verticillus, differ structurally at the C-terminal amines of
the glycopeptides. The biosynthesis of BLMs has been extensively studied by feeding isotope-labeled precursors [12,27–
29]. These results unambiguously established the hybrid peptide–polyketide origin of the BLMs, the aglycone of which
is derived from nine amino acids, an acetate, and two methyl
groups derived from S-adenosyl methionine (AdoMet) (Figure
2A). Subsequent isolation and structural determination of a
series of biosynthetic intermediates and shunt metabolites, including P-3A, P-4, P-5, and P-6m, from fermentation cultures
led to the hypothesis of a processive pathway for assembly of
the BLM hybrid peptide– polyketide backbone (Figure 2B). It
is noteworthy that such a hybrid peptide–polyketide biosyn378
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Figure 1 (A) PPTase-catalyzed posttranslational modification of apo-ACP/PCP into holo-ACP/PCP. (B) Hybrid NRPS/PKS-catalyzed C–C bond
formation in hybrid peptide/polyketide biosynthesis. (C) Hybrid PKS/ NRPS-catalyzed C–N bond formation in hybrid polyketide/peptide biosynthesis. These are hypothetical NRPS and PKS modules shown with only their respective core domains. Abbreviations for NRPS and PKS domains
are: A, adenylation; ACP, acyl carrier protein; AT, acyltransferase; C, condensation; KS, ketoacyl synthase; and PCP, peptidyl carrier protein.

thesis model, inspired mainly by the fatty acid synthase, was
put forward long before the characterization of the modular
structure of either NRPS or PKS. According to today’s hybrid
NRPS–PKS model [3,4,8,10], we could easily envisage biosynthesis of the BLM aglycone in three stages: (I) NRPS-mediated formation of P-3A from Ser, Asn, Asn, His, and Ala,
(II) PKS-mediated elongation of P-3A by malonyl CoA and
Adomet to yield P-4, and (III) NRPSmediated elongation of
P-4 by Thr to P-5 that is further elongated by β-Ala, Cys, and
Cys to generate P-6m (Figure 2B). Therefore, the transition
between stage I/II or II/III could potentially represent a natural hybrid NRPS/PKS (Figure 1B) or PKS/NRPS (Figure 1C)
system, respectively.
BLM megasynthetase as an example of natural hybrid NRPS–PKS systems
While the feeding experiments and the isolation of various biosynthetic and shunt metabolites motivated us to formulate the hybrid NRPS–PKS hypothesis for BLM biosynthesis,

it is the cloning and characterization of the BLM biosynthetic
gene cluster that provide direct evidence for the existence of
the BLM megasynthetase, a natural hybrid NRPS–PKS system that catalyzes the assembly of the BLM aglycone backbone from the amino acid and short carboxylic acid precursors
[6–10,23,24]. The blm gene cluster consists of 30 genes (Figure 3A), clustered with the blmA and blmB resistance genes
that confer BLM resistance by drug sequestering and drug
modification, respectively. Located in the center of the blm
gene cluster are 10 NRPS genes encoding nine NRPS modules and a PKS gene encoding one PKS module. We predicted
the substrate specificities of individual NRPS and PKS modules based on sequence analysis [5,7,15,26] and subsequently
confirmed the amino acid specificities of five NRPS modules
and the malonyl CoA specificity of the PKS module biochemically in vitro (Figure 3A).
On the basis of the BLM structure and the deduced functions of individual NRPS and PKS domains and modules, we
proposed a linear model for the BLM megasynthetase-templated assembly of the BLM peptide/polyketide/peptide agly-

380

S HEN

ET AL . IN

J. I NDUST . M ICROBIOL . & B IOTECH . 27 (2001)

Figure 2 (A) Structures of BLMs and primary biosynthetic precursors for the BLM aglycone. (B) The proposed biosynthetic pathway for BLMs involved a hybrid NRPS/ PKS/ NRPS system. The growing hybrid peptide–polyketide intermediates P-3A, P-4, P-5, and P-6m were isolated from
the wild-type S. verticillus fermentation and their structures were determined [12,27– 29].

cone from nine amino acids and one acetate (Figure 3B) [7].
Individual modules are first primed with the amino acid or
short carboxylic acid precursors, the choice of which is determined by the adenylation (A) domains of the NRPS modules or the acyltransferase (AT) domain of the PKS module,
respectively (Figure 3A). The BlmVI, BlmV, BlmX, BlmIXm
NRPS-mediated N-to-C directional assembly of the pseudopentapeptide intermediate proceeds by sequential condensation of Ser, Asn, Asn, His, and Ala, as evidenced by the isolation of P-3A (Figure 2B, stage I). In the next step, a malonate
reacts with the resulting pentapeptide intermediate to form a

β-ketothioester intermediate that is subsequently methylated
at the β-position and reduced at the β-keto group, and this proposal is consistent with the isolation of P-4 (Figure 2B, stage
II). The BlmVIII PKS module presumably dictates all these
biosynthetic events and interacts with the upstream BlmIX
NRPS module to channel the growing peptide intermediate
from an NRPS module to a PKS module. After one cycle of
polyketide elongation, peptide elongation is resumed by incorporation of a Thr residue. This step is catalyzed by the BlmVII NRPS module that interacts with the upstream BlmVIII
PKS module to channel the growing polyketide intermediate
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Figure 3 (A) Genetic organization of the BLM biosynthetic gene cluster [7]. Modules for individual NRPSand PKSare given along with their predicted or confirmed substrates (*) in parentheses. Three-letter amino acid designations were used. B, BamHI. (B) A linear model for the BLM megasynthetase-templated assembly of the BLM peptide/polyketide/peptide aglycone from nine amino acids and one acetate [7]. Abbreviations for
NRPSand PKS domains are: A, adenylation; ACP, acyl carrier protein; AL, acyl CoA ligase; AT, aclytransferase; C and C′, condensation; Cy, condensation/ cyclization; KR, ketoreductase; KS, ketoacyl synthase; MT, methyltransferase; Ox, oxidation; and PCP, peptidyl carrier protein. “NH2,”
an unspecified amino group donor.

(as far as the active site is concerned) from a PKS module to
an NRPS module. Subsequent elongation by three additional
NRPS modules (BlmIV and BlmIII) incorporates β-Ala and
two molecules of Cys into the BLM aglycone backbone (Figure 2B, stage III). Isolation of biosynthetic intermediates such
as P-5 and P-6m supports the latter proposal. Finally, the fully
assembled and modified BLM aglycone is released from the
BLM megasynthetase complex via a nucleophilic substitution
of the RCO-S-PCP species by an amine, RNH2. In contrast
to most of the NRPSs and PKSs known to date that release
the full-length peptide or polyketide intermediate from the
enzyme complex by a thioesterase domain [2–4], BlmII and
BlmXI, two discrete condensation enzymes identified within
the blm gene cluster, have been proposed to catalyze the latter
step [7]. Similar condensation (C) domain-catalyzed release
of either RCO-S-PCP from NRPS [18] or RCO-S-ACP from
PKS [17] has been proposed previously. The isolated biosynthetic intermediates, such as P-4, P-5, and P-5m, presumably

resulted from premature departure from the BLM megasynthetase complex before the growing chain reaches its full length.
Intermodular communication between BlmIX/
BlmVIII /BlmVII as an example of both hybrid NRPS/
PKS and hybrid PKS/NRPS systems
In peptide biosynthesis, the C–N bond formation is mediated by the C domain that catalyzes nucleophilic substitution
between the peptidyl-S-PCP from the upstream module, also
known as “donor site” substrate, and the amino group of its
cognate amino acyl-S-PCP, also known as “acceptor site” substrate [1,25]. In hybrid polyketide/peptide biosynthesis, however, the C domain of the hybrid PKS/NRPS mediates the
same C–N bond formation but by catalyzing the nucleophilic
substitution between the acyl-S-ACP of the PKS module and
the amino acyl-S-PCP of the NRPS (Figure 1C). This model
suggests that the critical domains for functional interaction
in a hybrid PKS/NRPS system should be the ACP and C do-
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Figure 4 Schematic representation of the BlmIX/BlmVIII/BlmVII system as a model for channeling the growing intermediate between NRPS and
PKSmodule s or between PKSand NRPSmodules for biosynthesis of hybrid peptide–polyketide natural products. The KS and ACP domains of Blm
VIII and the putative interpolypeptide linkers between BlmIX/BlmVIII and BlmVIII/BlmVII are shaded to emphasize their roles in facilitating interactions between NRPSand PKSto constitute a functional hybrid NRPS–PKSsystem.

mains of the PKS and NRPS modules, respectively. While the
acceptor site substrate of amino acyl-S-PCP remains the same,
the C domain in a hybrid PKS/ NRPS has to differentiate the
donor site substrate of acyl-S-ACP for polyketide/peptide biosynthesis from peptidyl-S-PCP for peptide biosynthesis.
In polyketide biosynthesis, the C–C bond formation is mediated by the KS domain that catalyzes (1) the transfer of the
acyl-S-ACP from the upstream module, the donor site substrate, to the active site cysteine of KS and (2) the decarboxylative condensation between the resulting acyl-S-KS and its
cognate malonyl-S-ACP, the acceptor site substrate [2– 4].
(Both “donor site” and “acceptor site” substrates for PKS are
defined in a mechanistic analogy to NRPS [1].) In hybrid peptide/polyketide biosynthesis, however, the KS domain of the
hybrid NRPS/PKS mediates the same C–C bond formation
but by catalyzing transfer of the peptidyl-S-PCP from the upstream NRPS module to the active site cysteine of KS to form
a peptidyl-S-KS species. The latter then undergoes similar decarboxylative condensation with its cognate malony-S-ACP to
yield the hybrid peptide/polyketide product (Figure 1B). According to this model, the critical domains for functional in-

teraction in a hybrid NRPS/PKS should be the PCP and KS
domains of the NRPS and PKS modules, respectively. While
the acceptor site substrate of malonyl-S-ACP remains the
same, the KS domain in a hybrid NRPS/PKS has to differentiate the donor site substrate of peptidyl-S-PCP for hybrid peptide/polyketide biosynthesis from acyl-S-ACP for polykeptide
biosynthesis.
Many bacterial genomes encode multiple peptide and/
or polyketide pathways, each of which is composed of multiple PKS or NRPS modules. However, there is no evidence
for crosstalk either among NRPS or PKS modules or between
NRPS or PKS modules that belong to different peptide or
polyketide pathways. In fact, NRPS or PKS modules constitute the NRPS or PKS megasynthetase with a precise selectivity, as evidenced by the fact that most of the NRPS or PKS
pathways often produce only one major peptide or polyketide
product out of a myriad of possibilities. These observations
suggest the existence of extensive intermodular communication among modules that constitute the NRPS or PKS megasynthetases, raising an interesting question of how NRPS
and PKS modules communicate to form hybrid NRPS–PKS
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systems. BlmIX/BlmVIII/BlmVII constitutes a natural hybrid
NRPS/PKS/NRPS system, combining features of both hybrid
NRPS/PKS and PKS/NRPS systems. We, therefore, reasoned
that a detailed comparison of BlmIX/BlmVIII/BlmlVII with
NRPS and PKS modules in nonhybrid systems could shed
light on the mechanism for NRPS and PKS modules to constitute either hybrid NRPS/PKS or PKS/NRPS systems.
For BlmIX/BlmVIII, we found that the PCP domain of
BlmIX seems to have no relevant difference compared to
those in nonhybrid NRPS systems. In contrast, the KS domain
of BlmVIII is unique in comparison with those in nonhybrid
PKS systems. Upon phylogenic analysis, the KS domain of
BlmVIII can be grouped into a subfamily of KSs from all
other known hybrid NRPS/PKS systems regardless of their
origins. Therefore, the BlmVIII PKS may have evolved a KS
domain with an altered donor site substrate specificity to adapt
the BlmIX-bound peptidyl-S-PCP intermediate (Figure 4, step
a). Once the peptidyl intermediate is transferred to the active
site cysteine of the KS domain, BlmVIII appears to utilize the
same catalytic sites conserved in all other PKS domains to execute the decarboxylative condensation with the acceptor substrate of malonyl-S-ACP (Figure 4, step b) and the associated
modifications (Figure 4, steps c and d) to yield the resultant
peptide/polyketide product [7,8].
For BlmVIII/BlmVII, we found that the ACP domain of
BlmVIII is more similar to PCPs than to ACPs but the C domain of BlmVII shows no unique features compared to those
in nonhybrid NRPSs [7,8]. These findings are in accordance
with (1) the proposed function for the carrier proteins of
both PKS and NRPS as workstations without any selectivity
[11,16] and (2) the low selectivity of the NRPS C domain toward the donor site substrate [1]. Physical proximity of the active sites may be sufficient for the C domain to accept the donor site substrate of acyl-S-ACP, instead of peptidyl-S-PCP,
and to catalyze its elongation with the acceptor site substrate
of amino acyl-S-PCP to afford the hybrid polyketide/peptide
product (Figure 4, step e) [7,8].
Intermodular communications in PKS have been attributed to either intermodular linkers that exist between modules
within a protein or interpolypeptide linkers that exist between
modules residing on separate proteins [13,14]. Polyketide
chain transfer between modules appears to be permissive as
long as the linkers can provide the connectivity between the
adjacent modules [14]. Inspired by the linker hypothesis for
PKS, we carried out similar sequence analyses for hybrid
NRPS–PKS systems with the intention of identifying analogous linkers [8]. It is hoped that the specificities of the linkers
between nonhybrid NRPS or PKS systems and hybrid NRPS–
PKS systems may provide insight into the evolution of NRPS
and PKS modules into hybrid NRPS–PKS systems. We have
indeed identified putative interpolypeptide linkers for both hybrid NRPS/PKS and hybrid PKS/NRPS systems. They are located at the C-termini of the NRPS proteins and N-terminal of
the PKS proteins for hybrid NRPS/PKS systems and the C-termini of the PKS proteins and N-termini of the NRPS proteins
for PKS/NRPS systems. The linkers vary from 5 to 76 amino
acids and are rich in acidic residues [8]. It is tempting to pro-

pose that these linkers may play a critical role in protein–protein recognition to constitute a functional hybrid NRPS–PKS
system, as depicted for BlmIX/ BlmVIII/BlmVII (Figure 4).
However, the latter conclusion is based purely on sequence
analysis and has to be assessed experimentally in the future.
Posttranslational modification of the carrier proteins of hybrid NRPS–PKS systems by a PPTase
with broad substrate specificity
For NRPS and PKS to be functional, their carrier proteins
must be converted from the apo forms to the holo forms by
covalent attachments of the 4′-phosphopantetheine group to
an absolutely conserved serine residue. This posttranslational
modification is catalyzed by a superfamily of enzymes known
as PPTases that derive the 4′-phosphopantetheine group from
coenzyme A (CoA) (Figure 1A) [20,31]. Most of the PPTases
characterized to date exhibit high specificity toward the carrier protein substrates, leading to the proposal that each 4′phosphopantetheine-requiring pathway has its own posttranslational modifying PPTase activity [31]. However, a
functional hybrid NRPS–PKS system requires a PPTase that
is capable of modifying the apo forms of both PCP and ACP
into their holo forms. Because all PPTases characterized to
date are associated with fatty acid, polyketide, or peptide biosynthetic pathways, we were particularly interested in finding
out if a PPTase from organisms that produce hybrid peptide–
polyketide natural products exhibits relaxed specificity toward
both ACPs and PCPs.
Most of the PPTases known to date were identified either by association with a peptide or polyketide biosynthetic
gene cluster or by whole genome sequencing. Sequence analysis of the blm biosynthetic gene cluster, however, failed to
reveal an associated PPTase gene, suggesting that the blm
NRPS and PKS genes are not clustered with their PPTase
gene [7]. To clone a PPTase gene from S. verticillus, we developed a PCR method using primers designed according to
two conserved motifs among PCP-specific PPTases of actinomycete origin. The cloned Svp PPTase gene is mapped to
an independent locus not clustered with any of the NRPS or
PKS loci previously known to S. verticillus, including the
blm hybrid peptide–polyketide gene cluster. The Svp protein
was overproduced in E. coli, purified to homogeneity, and determined to be a monomer in solution. We have been able to
show that Svp can efficiently 4′-phosphopantetheinate both
type I and type II ACPs and PCPs from either S. verticillus
or other Streptomyces species [23]. As compared to Sfp, the
only other PPTase known to accept ACPs, ArCPs, and PCPs
from various organisms, Svp displays a similar catalytic efficiency for PCPs but a 345-fold increase in catalytic efficiency
for the tested ACP. Sfp, isolated from Bacillus subtilis, is clustered with the biosynthetic genes for the nonribosomal peptide
antibiotic surfactin [21]. Sfp has been called a “promiscuous”
PPTase, because (1) all other known PPTases, associated with
fatty acid, peptide or polyketide biosynthetic gene clusters,
are specific for their respective ACPs or PCPs, and (2) surfactin biosynthesis does not require the participation of an ACP
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[20–22,31]. In contrast, we argued that the broad substrate
specificity of Svp toward various carrier proteins is an intrinsic property for PPTases that are generally responsible for secondary metabolite biosynthesis. These PPTases are nonessential for the producing organisms and, therefore, may evolve
new or broad substrate specificity toward their carrier proteins
including both PCPs and ACPs for hybrid peptide– polyketide
biosynthesis [23]. Although we have shown that S. verticillus
appears to have evolved a single PPTase, Svp, to posttranslationally modify the BLM hybrid NRPS–PKS system, it is
yet to be determined if a PPTase with a broad carrier protein
specificity is a general solution to provide functional hybrid
NRPS–PKS systems for hybrid peptide–polyketide natural
product biosynthesis.

National Institutes of Health training grant T32GM07377; and
J.M.M was supported in part by the Biotechnology Training
Grant from the University of California, Davis.

Concluding remarks
BLM is an example of hybrid peptide–polyketide natural products. The peptide/polyketide/peptide backbone of
the BLM aglycone is assembled by the BLM megasynthetase that consists of both NRPS and PKS modules. BlmIX/
BlmVIII /BlmVII constitute a natural hybrid NRPS/PKS and
PKS/NRPS system, catalyzing the elongation of a peptidyl intermediate with a short carboxylic acid and a polyketide intermediate with an amino acid. This system therefore serves
as a model for both hybrid NRPS/ PKS and PKS/NRPS systems. While biochemical data are still lacking, sequence analysis and functional comparison of domains and modules of
BlmIX/BlmVIII /BlmVII with those of nonhybrid NRPS and
PKS systems are beginning to shed light on hybrid peptide–
polyketide biosynthesis. The same catalytic sites appear to be
conserved in both hybrid NRPS–PKS and nonhybrid NRPS or
PKS systems, with the exception of the KS domains in the hybrid NRPS/PKS systems that are unique. Specific linkers, confirmed for PKS [13,14], and proposed for NRPS and hybrid
NRPS–PKS systems [8], may play a critical role in intermodular communication to facilitate the transfer of the growing
intermediates between the interacting NRPS and/or PKS modules. In order to be functional, hybrid NRPS–PKS systems require PPTases that should be capable of posttranslationally
modifying the apo forms of both PCP and ACP into their holo
forms. For the BLM megasynthetase, this modification has
been accomplished by evolving a single PPTase, Svp, with a
broad substrate specificity toward the apo forms of both ACPs
and PCPs. These findings should now help us to formulate research ideas and experimental strategies for studying the biosynthesis of hybrid peptide– polyketide natural products.
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